Globus Medical, Inc. GMED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 763.72M | 789.61M | 759.85M | 826.42M | 769.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 763.72M | 789.61M | 759.85M | 826.42M | 769.05M |
| Cost of Revenue | 232.92M | 241.44M | 234.07M | 254.63M | 245.58M |
| Gross Profit | 530.80M | 548.17M | 525.79M | 571.80M | 523.47M |
| SG&A Expenses | 284.81M | 286.76M | 297.77M | 304.78M | 285.33M |
| Depreciation & Amortization | 29.57M | 29.56M | 29.53M | 29.36M | 29.84M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 581.83M | 594.08M | 597.87M | 624.93M | 598.81M |
| Operating Income | 181.89M | 195.53M | 161.98M | 201.49M | 170.23M |
| Income Before Tax | 183.27M | 189.82M | 157.07M | 169.23M | 143.99M |
| Income Tax Expenses | 42.10M | 38.25M | 32.77M | 28.64M | 25.03M |
| Earnings from Continuing Operations | 141.17M | 151.57M | 124.30M | 140.59M | 118.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 141.17M | 151.57M | 124.30M | 140.59M | 118.97M |
| EBIT | 181.89M | 195.53M | 161.98M | 201.49M | 170.23M |
| EBITDA | 252.09M | 265.11M | 231.93M | 270.31M | 241.20M |
| EPS Basic | 1.05 | 1.12 | 0.92 | 1.05 | 0.88 |
| Normalized Basic EPS | 0.87 | 0.94 | 0.77 | 0.92 | 0.80 |
| EPS Diluted | 1.04 | 1.10 | 0.90 | 1.02 | 0.88 |
| Normalized Diluted EPS | 0.86 | 0.92 | 0.76 | 0.91 | 0.80 |
| Average Basic Shares Outstanding | 134.15M | 135.05M | 135.36M | 134.41M | 134.50M |
| Average Diluted Shares Outstanding | 136.02M | 137.38M | 138.19M | 136.57M | 135.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |